28 July 2020

MBI Colloquium 2020

The MBI annual colloquium is open to anyone with an interest in the areas of emerging/re-emerging infectious diseases and biosecurity, with a particular emphasis on the Asia-Pacific region.
13 July 2020

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

Examining the added value of near real-time genome sequencing of SARS-CoV-2 in a subpopulation of infected patients during the first 10 weeks of COVID-19 containment in Australia and compare findings from genomic surveillance with predictions of a computational agent-based model (ABM).
07 July 2020

MRFF grant success

Australian Government invests in cutting-edge research projects and clinical trials to drive new ideas and achieve new discoveries to improve quality of life and survival rates, and boost our nation’s strong reputation as a global leader in medical research.
07 July 2020

Global antimicrobial resistance and use surveillance system (GLASS) report

Launched in 2015 by the World Health Organization, GLASS has been conceived to progressively incorporate data from surveillance of AMR in humans, such as monitoring of resistance, use of antimicrobial medicines, AMR in the food chain and in the environment.
02 July 2020

Pathogen Genomics: Empowering Infectious Disease Surveillance and Outbreak Investigations

MBI's Professor Vitali Sintchenko editorial article assembles articles on genomic epidemiological approaches to identify sources and mechanisms of transmission of infection and antimicrobial resistance. 

02 July 2020

Research to fight antimicrobial resistance and TB in the Pacific

This research will be led by MBI's Co-Director, Professor Ben Marais, and will include trialling bold new strategies to reduce and eventually eliminate DR-TB in the Pacific.